Search - tctmd.com

Displaying 181 - 200 of 307

Sort: Relevancy | Date

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

News Daily News

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Yael L. Maxwell

December 14, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

Shelley Wood

December 03, 2021

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Shelley Wood

November 15, 2021

News Conference News AHA 2021

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Michael O'Riordan

November 13, 2021

News Daily News

Zero CAC Questionable for Ruling Out Obstructive CAD in Young Adults

Michael O'Riordan

November 02, 2021

News Daily News

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

October 15, 2021

News Daily News

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

Yael L. Maxwell

October 14, 2021

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

Shelley Wood

October 01, 2021

Podcast Heart Sounds

Top News in Cardiology: September 2021

September 29, 2021

News Daily News

Early Menopause Linked to Increased ASCVD Risk

L.A. McKeown

September 17, 2021

News Daily News

Heterozygous FH Diagnosed Late, Remains Undertreated

Michael O'Riordan

September 13, 2021

News Daily News

Could an App Replace Statin Prescribing by Doctors?

Michael O'Riordan

September 08, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

News Conference News ESC 2021

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Michael O'Riordan

August 30, 2021

News Daily News

Statins Positively Alter Coronary Plaque Composition

Michael O'Riordan

August 23, 2021

Advertisement

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

British Medical Groups Express Concern About Inclisiran Rollout

Another Study Links Stopping Statins to MACE in the Elderly

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Zero CAC Questionable for Ruling Out Obstructive CAD in Young Adults

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

TCTMD’s Top 10 Most Popular Stories for September 2021

Top News in Cardiology: September 2021

Early Menopause Linked to Increased ASCVD Risk

Heterozygous FH Diagnosed Late, Remains Undertreated

Could an App Replace Statin Prescribing by Doctors?

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Statins Positively Alter Coronary Plaque Composition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content